or
forgot password
  • cancer clinical trials in rochester, MN

  • Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
    Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lymphoma
    Creatine in Treating Patients With Cancer-Associated Weight Loss
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    Mayo Clinic
    Rochester, Minnesota 55905
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Anaplastic Large Cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Small Lymphocytic Lymphoma, Splenic Marginal Zone Lymphoma
    Erlotinib and Tipifarnib in Treating Patients With Advanced Solid Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Unspecified Adult Solid Tumor, Protocol Specific
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Kidney Cancer
    Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Mayo Clinic
    Rochester, Minnesota 55905
    B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage III Small Lymphocytic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Small Lymphocytic Lymphoma, T-cell Large Granular Lymphocyte Leukemia
    Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
    Mayo Clinic (Adult Site)

    Trial Locations
    Mayo Clinic (Adult Site)
    Mayo Clinic (Pediatric Site)
    Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis
    A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers.
    Mayo Clinic - Rochester
    Rochester, Minnesota 55905
    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome, Systemic Mastocytosis
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Mantle Cell Lymphoma
    CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Multiple Myeloma and Plasma Cell Neoplasm
    Temozolomide and Radiation Therapy in Treating Patients With Gliomas
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain and Central Nervous System Tumors
    Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Thyroid Cancer, Stage IV Follicular Thyroid Cancer, Stage IV Papillary Thyroid Cancer, Thyroid Gland Medullary Carcinoma
    Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Gastrinoma, Glucagonoma, Insulinoma, Metastatic Gastrointestinal Carcinoid Tumor, Neuroendocrine Tumor, Pancreatic Polypeptide Tumor, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Islet Cell Carcinoma, Somatostatinoma, WDHA Syndrome
    Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Liver Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Prolonged Smoking Cessation Using Prescription Step Care
    Mayo Clinic
    Rochester, Minnesota 55905
    Tobacco Dependence
    Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.
    Mayo Clinic
    Rochester, Minnesota 55905
    Hepatitis C Virus, Advanced Fibrosis, Cirrhosis
    Octreotide in Treating Patients With Cancer-Related Malignant Ascites
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Chronic Myeloproliferative Disorders
    Radiation Therapy in Treating Young Patients With Gliomas
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain Tumor, Central Nervous System Tumor
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Bevacizumab in Treating Patients With Angiosarcoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Sarcoma
    Familial Barrett's Esophagus
    Mayo Clinic
    Rochester, Minnesota 55905
    Barrett's Esophagus, Esophageal Neoplasm
    Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
    Mayo Clinic
    Rochester, Minnesota 55905
    B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Mayo Clinic
    Rochester, Minnesota 55905
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Mayo Clinic
    Rochester, Minnesota 55905
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Mayo Clinic
    Rochester, Minnesota 55905
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Evaluation of DHA for the Treatment of PSC
    Mayo Clinic
    Rochester, Minnesota 55905
    Primary Sclerosing Cholangitis, Colitis
    AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
    Mayo Clinic
    Rochester, Minnesota 55905
    Neurofibromatosis Type 1, Plexiform Neurofibroma, Spinal Cord Neurofibroma
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Mayo Clinic
    Rochester, Minnesota 55905
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Mayo Clinic

    Trial Locations
    Mayo Clinic
    North Central Cancer Treatment Group
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Mayo Clinic
    Rochester, Minnesota 55905
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    AFP464 in Treating Patients With Advanced Solid Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Male Breast Cancer, Recurrent Breast Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Renal Cell Cancer, Stage IV Breast Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Renal Cell Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Lung Rehabilitation in Treating Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Surgery for Lung Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Lung Cancer, Perioperative/Postoperative Complications, Pulmonary Complications, Tobacco Use Disorder
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Leukemia, Myelodysplastic Syndromes